Eckelman Brendan P.
Insider CIK 1766433 · INBX Chief Scientific Officer, Director · INXB Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INXB Inhibrx Biosciences, Inc. | A Award deriv | 2024-05-30 | 2024-05-30 | 175,000 | — | $0 | 175,000 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 26,667 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 6,667 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer | 2024-05-30 | 2024-05-30 | 1,735,553 | $30.00 | $52.07M | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer | 2024-05-30 | 2024-05-30 | 160,000 | $30.00 | $4.80M | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer | 2024-05-30 | 2024-05-30 | 160,000 | $30.00 | $4.80M | 0 | SEC↗ |
| INXB Inhibrx Biosciences, Inc. | A Award | 2024-05-29 | 2024-05-30 | 40,000 | — | $0 | 40,000 | SEC↗ |
| INXB Inhibrx Biosciences, Inc. | A Award | 2024-05-29 | 2024-05-30 | 40,000 | — | $0 | 40,000 | SEC↗ |
| INXB Inhibrx Biosciences, Inc. | A Award | 2024-05-29 | 2024-05-30 | 433,888 | — | $0 | 433,888 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2024-05-28 | 2024-05-30 | 300,000 | $34.30 | $10.29M | 1,735,553 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-05-22 | 2024-05-24 | 2,500 | $34.12 | $85.3K | 26,667 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-05-22 | 2024-05-24 | 2,510 | $34.12 | $85.6K | 6,667 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-13 | 2024-03-15 | 1,898 | $35.33 | $67.1K | 9,177 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-12 | 2024-03-12 | 19,898 | $35.25 | $701.4K | 11,075 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-12 | 2024-03-12 | 4,152 | $35.25 | $146.4K | 29,167 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-11 | 2024-03-12 | 6,877 | $35.30 | $242.8K | 30,973 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-11 | 2024-03-12 | 6,681 | $35.33 | $236.0K | 33,319 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-08 | 2024-03-12 | 2,150 | $35.75 | $76.9K | 37,850 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-03-01 | 2023-03-02 | 400 | $24.71 | $9.9K | 2,035,553 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-03-01 | 2023-03-02 | 39,600 | $24.20 | $958.3K | 2,035,953 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-02-02 | 2023-02-02 | 1,130 | $25.89 | $29.3K | 2,075,553 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-02-02 | 2023-02-02 | 10,120 | $25.40 | $257.0K | 2,076,683 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-02-01 | 2023-02-02 | 693 | $25.66 | $17.8K | 2,086,803 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-02-01 | 2023-02-02 | 13,449 | $24.29 | $326.7K | 2,102,104 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-02-01 | 2023-02-02 | 14,608 | $25.08 | $366.4K | 2,087,496 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-01-04 | 2023-01-04 | 3,003 | $23.99 | $72.0K | 2,115,553 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-01-04 | 2023-01-04 | 4,102 | $23.11 | $94.8K | 2,118,556 | SEC↗ |
| INBX Inhibrx, Inc. | A Award deriv | 2023-01-03 | 2023-01-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-01-03 | 2023-01-04 | 2,084 | $25.09 | $52.3K | 2,122,658 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-01-03 | 2023-01-04 | 8,598 | $24.36 | $209.4K | 2,124,742 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-01-03 | 2023-01-04 | 22,213 | $23.41 | $520.0K | 2,133,340 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-12-06 | 2022-12-07 | 1,392 | $28.46 | $39.6K | 2,155,553 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-12-06 | 2022-12-07 | 17,681 | $27.57 | $487.5K | 2,156,945 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-12-06 | 2022-12-07 | 20,927 | $26.83 | $561.5K | 2,174,626 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 27,651 | $33.34 | $921.9K | 2,207,902 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 12,349 | $33.90 | $418.6K | 2,195,553 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-10-04 | 2022-10-05 | 1,448 | $24.67 | $35.7K | 2,274,105 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-10-04 | 2022-10-05 | 4,262 | $27.76 | $118.3K | 2,252,500 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-10-04 | 2022-10-05 | 6,207 | $26.06 | $161.8K | 2,267,898 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-10-04 | 2022-10-05 | 100 | $30.52 | $3.1K | 2,235,553 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-10-04 | 2022-10-05 | 10,893 | $29.68 | $323.3K | 2,235,653 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-10-04 | 2022-10-05 | 5,954 | $28.97 | $172.5K | 2,246,546 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-10-04 | 2022-10-05 | 11,136 | $26.78 | $298.2K | 2,256,762 | SEC↗ |
| INBX Inhibrx, Inc. | G Gift | 2022-09-13 | 2022-09-14 | 160,000 | — | $0 | 2,275,553 | SEC↗ |
| INBX Inhibrx, Inc. | G Gift | 2022-09-13 | 2022-09-14 | 80,000 | — | $0 | 160,000 | SEC↗ |
| INBX Inhibrx, Inc. | G Gift | 2022-09-13 | 2022-09-14 | 80,000 | — | $0 | 160,000 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-09-06 | 2022-09-07 | 2,493 | $15.66 | $39.0K | 2,435,553 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-09-06 | 2022-09-07 | 37,507 | $14.86 | $557.4K | 2,438,046 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-08-03 | 2022-08-04 | 15,500 | $18.47 | $286.3K | 2,475,553 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-08-02 | 2022-08-04 | 24,500 | $17.70 | $433.6K | 2,491,053 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-07-07 | 2022-07-08 | 40,000 | $17.17 | $686.8K | 2,515,553 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-04-05 | 2022-04-07 | 400 | $25.04 | $10.0K | 2,555,553 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2021-03-24 | 2021-03-24 | 17,000 | $19.02 | $323.3K | 2,555,953 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2021-02-16 | 2021-02-18 | 17,000 | $25.90 | $440.3K | 2,572,953 | SEC↗ |
| INBX Inhibrx, Inc. | A Award deriv | 2021-01-15 | 2021-01-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| INBX Inhibrx, Inc. | G Gift | 2020-12-04 | 2021-01-19 | 80,000 | — | $0 | 80,000 | SEC↗ |
| INBX Inhibrx, Inc. | G Gift | 2020-12-04 | 2021-01-19 | 80,000 | — | $0 | 80,000 | SEC↗ |
| INBX Inhibrx, Inc. | G Gift | 2020-12-04 | 2021-01-19 | 160,000 | — | $0 | 2,589,953 | SEC↗ |